CILP attenuates pulmonary fibrosis through the TGF-β1/SMAD3 pathway
Abstract Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disease with poor survival, which is characterized by abnormal accumulation of fibrotic tissue in the lung parenchyma. Transforming growth factor-β1 (TGF-β) is a central profibrotic mediator, but the related mechanism of the activ...
Gardado en:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2025-12-01
|
| Series: | European Journal of Medical Research |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s40001-025-03644-7 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|